FDA PMA FDA Class 3 Approved 🇺🇸 United States

Implanted Phrenic Nerve Stimulator For Central Sleep Apnea

PMA: P160039 · Supplement: S008 · Decision Mar 28, 2023
Classifications
1
FEI Numbers
3
Registration Numbers
3

Basic Information

Device Name
Implanted Phrenic Nerve Stimulator For Central Sleep Apnea
Trade Name
remede® System
PMA Number
P160039
Supplement Number
S008
Device Class
FDA Class 3
Product Code
PSR
Generic Name
Implanted phrenic nerve stimulator for central sleep apnea
Medical Specialty
Unknown
Advisory Committee
Anesthesiology
Decision
Approved
Decision Code
APPR
Decision Date
March 28, 2023
Date Received
March 1, 2022
Supplement Type
Normal 180 Day Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval for adding MR Conditional labeling for 1.5T and 3T MRI scans to the implantable components of remede System.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PSR Implanted Phrenic Nerve Stimulator For Central Sleep Apnea